Novel Agents http://www.acc.org/Feed?clinicalTopicID=a6997643-d7bf-4b8d-b578-d65877161636 Clinical Topic Feed: Novel Agents en Are There Sex Differences in Diagnosis, Treatment, CV Outcomes For Patients With HoFH? /Latest-in-Cardiology/Articles/2024/03/06/15/02/are-there-sex-differences-in-diagnosis-treatment-cv-outcomes-for-patients-with-hofh In an international cohort of patients with homozygous familial hypercholesterolemia (HoFH), the incidence of myocardial infarction (MI) was higher in men than women, but no difference was found between men and women for the age when HoFH was diagnosed or when the first atherosclerotic cardiovascular disease (ASCVD) event occurred, according to a study published Feb. 14 in JAMA Cardiology. 1709737560000 Articles and Stories I Am an Athlete: Will This Statin Affect My Performance? /Latest-in-Cardiology/Articles/2024/03/05/12/10/i-am-an-athlete A 59-year-old woman with newly diagnosed nonobstructive coronary artery disease (CAD) presents to the sports cardiology clinic. She is a long-distance runner who has participated in numerous marathons over the previous 20 years. 1709667480000 Articles and Stories Thrombolysis in Imaging-Eligible, Late-Window Patients to Assess the Efficacy and Safety of Tenecteplase /Latest-in-Cardiology/Clinical-Trials/2024/02/20/13/39/timeless The goal of the TIMELESS trial was to determine the efficacy and safety of tenecteplase administered between 4.5 and 24 hours after last known well time in patients with acute ischemic stroke and salvageable tissue on perfusion imaging. 1708405200000 Articles and Stories Approach to Statin Intolerance Within the Risk Reduction Toolbox /Education-and-Meetings/Patient-Case-Quizzes/2023/10/13/12/35/Approach-to-Statin-Intolerance A 60-year-old female patient presents to the clinic for follow up. She has a history of hypertension, hyperlipidemia, and prior angina. 1698165600000 Educational Activities Reviewing Non-Statin Options: Choosing the Best Treatment Plan /Education-and-Meetings/Patient-Case-Quizzes/2023/10/13/12/35/Reviewing-Non-Statin-Options The patient is a 58-year-old man with a history of coronary artery disease including a history of myocardial infarction (MI) treated with a percutaneous coronary intervention to the proximal left anterior descending artery (LAD)... 1698165600000 Educational Activities Is Age a Factor in Clinical Effectiveness of Lipid-Lowering Therapy For CVD Prevention? /Latest-in-Cardiology/Articles/2023/10/16/17/56/Is-Age-a-Factor-in-Clinical-Effectiveness-of-Lipid-Lowering-Therapy-For-CVD-Prevention The clinical effectiveness of lowering LDL-C with lipid-lowering therapy (LLT) for primary prevention of atherosclerotic cardiovascular disease (ASCVD) was similar among individuals younger and older than 70 years, according to a cohort study published Oct. 3 in JACC. 1697479440000 Articles and Stories Eagle’s Eye View: What are the Benefits and Drawbacks of Vegetarian and Vegan Diets? /Latest-in-Cardiology/Articles/2023/10/04/16/25/eagles-eye-view-04oct2023 In this week’s View, Dr. Eagle explores the benefits and drawbacks of vegetarian and vegan diets. He then discusses LDL cholesterol reduction for primary prevention of major vascular events in the elderly. 1696436820000 Articles and Stories Fluoroquinolone and Aortic Aneurysm or Dissection /Latest-in-Cardiology/Journal-Scans/2023/10/02/14/07/lack-of-association-between Is there an increased risk of aortic aneurysm (AA) or aortic dissection (AD) associated with fluoroquinolone (FQ) use? 1696271100000 Articles and Stories What Contributes to the Higher Stroke Risk in Women With AFib? /Latest-in-Cardiology/Articles/2023/09/18/16/36/What-Contributes-to-the-Higher-Stroke-Risk-in-Women-With-AFib Female sex is associated with higher stroke rates among those with atrial fibrillation (AFib) after adjusting for other CHA2DS2-VASc risk factors, and older age and inequities in cardiovascular care may be contributing to these higher rates... 1695057660000 Articles and Stories 2023 ESC Guidelines for Managing CVD in Diabetes: Key Points—Part 1 /Latest-in-Cardiology/ten-points-to-remember/2023/09/08/18/40/2023-esc-guidelines-cvd-diabetes-part-1-esc-2023 The following are key points to remember from the 2023 European Society of Cardiology (ESC) guidelines for the management of cardiovascular disease (CVD) in patients with diabetes, part 1. 1694448540000 Articles and Stories